{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:33:00Z","timestamp":1787682780385,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.autrev.2020.102694","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T02:04:25Z","timestamp":1603418665000},"page":"102694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Overview of IgG4-related aortitis and periaortitis. A decade since their first description"],"prefix":"10.1016","volume":"19","author":[{"given":"Elena","family":"Nikiphorou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Fragoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.autrev.2020.102694_bb0005","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.autrev.2020.102694_bb0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/bjs.1800590807","article-title":"Inflammatory aneurysms of the abdominal aorta","volume":"59","author":"Walker","year":"1972","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/BOR.0b013e32833ee95f","article-title":"IgG4-related inflammatory abdominal aortic aneurysm","volume":"23","author":"Kasashima","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/BOR.0b013e3283412f7c","article-title":"Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease","volume":"23","author":"Stone","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102694_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/PAS.0b013e3181342f0d","article-title":"Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis","volume":"32","author":"Kasashima","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102694_bb0030","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jvs.2010.06.072","article-title":"A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta","volume":"52","author":"Kasashima","year":"2010","journal-title":"J Vasc Surg"},{"issue":"10","key":"10.1016\/j.autrev.2020.102694_bb0035","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1002\/art.24798","article-title":"IgG4-related systemic disease and lymphoplasmacytic aortitis","volume":"60","author":"Stone","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-017-1432-8","article-title":"Clinical features of IgG4-related periaortitis\/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study","volume":"19","author":"Ozawa","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2020.102694_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1536\/ihj.13-321","article-title":"IgG4-related cardiovascular disorders","volume":"55","author":"Tajima","year":"2014","journal-title":"Int Heart J"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12872-017-0488-3","article-title":"IgG4-positive cell infiltration in various cardiovascular disorders - results from histopathological analysis of surgical samples","volume":"17","author":"Hourai","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"28","key":"10.1016\/j.autrev.2020.102694_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003344","article-title":"Large vessel involvement by IgG4-related disease","volume":"95","author":"Perugino","year":"2016","journal-title":"Medicine."},{"issue":"10","key":"10.1016\/j.autrev.2020.102694_bb0060","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2020.102694_bb0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/acr.20095","article-title":"IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases","volume":"62","author":"Stone","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.autrev.2020.102694_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.carpath.2010.09.003","article-title":"Isolated thoracic aortitis: clinicopathological and immunohistochemical study of 11 cases","volume":"20","author":"Laco","year":"2011","journal-title":"Cardiovasc Pathol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102694_bb0075","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/1756-185X.13194","article-title":"Clinical characteristics and outcomes of 61 patients with chronic periaortitis including IgG4-related and non-IgG4-related cases","volume":"20","author":"Kim","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2020.102694_bb0080","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/keu462","article-title":"IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis?","volume":"54","author":"Castelein","year":"2015","journal-title":"Rheumatology."},{"issue":"4","key":"10.1016\/j.autrev.2020.102694_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.semdp.2012.07.003","article-title":"Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease","volume":"29","author":"Zen","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3400\/avd.ra.18-00012","article-title":"IgG4-related arterial disease","volume":"11","author":"Kasashima","year":"2018","journal-title":"Ann Vasc Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102694_bb0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/1756-185X.12279","article-title":"Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises","volume":"17","author":"Koo","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102694_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2018-314499","article-title":"IgG4-aortitis among thoracic aortic aneurysms","author":"Perez-Garcia","year":"2019","journal-title":"Heart."},{"issue":"6","key":"10.1016\/j.autrev.2020.102694_bb0105","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jtcvs.2012.09.039","article-title":"Immunoglobulin G4-positive ascending thoracic aortitis may be prone to dissection","volume":"146","author":"Kajander","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.autrev.2020.102694_bb0110","first-page":"1713","article-title":"Inflammatory thoracic aortic aneurysm (lymphoplasmacytic thoracic aortitis): a 13-year-experience at a German Heart Center with emphasis on possible role of IgG4","volume":"6","author":"Agaimy","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102694_bb0115","doi-asserted-by":"crossref","first-page":"102354","DOI":"10.1016\/j.autrev.2019.102354","article-title":"Characteristics and prognosis of IgG4-related periaortitis\/periarteritis: a systematic literature review","volume":"18","author":"Akiyama","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2020.102694_bb0120","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jvs.2008.11.072","article-title":"A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm","volume":"49","author":"Kasashima","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.autrev.2020.102694_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13307","article-title":"Abdominal aortic aneurysm as an IgG4-related disease","author":"Prucha","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"15","key":"10.1016\/j.autrev.2020.102694_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine."},{"issue":"7","key":"10.1016\/j.autrev.2020.102694_bb0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.autrev.2006.03.011","article-title":"Autoimmune aspects of chronic periaortitis","volume":"5","author":"Vaglio","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2020.102694_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2020.102694_bb0145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(03)00056-1","article-title":"Evidence of autoimmunity in chronic periaortitis: a prospective study","volume":"114","author":"Vaglio","year":"2003","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.autrev.2020.102694_bb0150","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/1756-185X.12863","article-title":"IgG4-related retroperitoneal fibrosis: a newly characterized disease","volume":"19","author":"Lian","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ekir.2018.08.011","article-title":"Clinical manifestations and long-term outcomes of IgG4-related kidney and retroperitoneal involvement in a United Kingdom IgG4-related disease cohort","volume":"4","author":"Evans","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European league against rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2020.102694_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","article-title":"Rethinking Ormond\u2019s disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease","volume":"92","author":"Khosroshahi","year":"2013","journal-title":"Medicine."},{"issue":"2","key":"10.1016\/j.autrev.2020.102694_bb0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/14397595.2014.931908","article-title":"Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis","volume":"25","author":"Koo","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"9788","key":"10.1016\/j.autrev.2020.102694_bb0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","article-title":"Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial","volume":"378","author":"Vaglio","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2020.102694_bb0180","first-page":"1","article-title":"IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study","author":"Lomborg","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102694_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5414\/CNCS109321","article-title":"Rituximab for retroperitoneal fibrosis due to IgG4-related disease: a case report and literature review","volume":"6","author":"Almeqdadi","year":"2018","journal-title":"Clin Nephrol Case Stud"},{"issue":"12","key":"10.1016\/j.autrev.2020.102694_bb0190","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","article-title":"Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.autrev.2020.102694_bb0195","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.molmed.2008.09.008","article-title":"Abdominal aortic aneurysms: an autoimmune disease?","volume":"14","author":"Jagadesham","year":"2008","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/j.autrev.2020.102694_bb0200","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jvs.2006.12.055","article-title":"Impaired Fas-induced apoptosis of T lymphocytes in patients with abdominal aortic aneurysms","volume":"45","author":"Zhang","year":"2007","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/bjs.5215","article-title":"Increased natural killer cell activity in patients with an abdominal aortic aneurysm","volume":"93","author":"Forester","year":"2006","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.autrev.2020.102694_bb0210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.berh.2008.12.002","article-title":"Chronic periaortitis: a fibro-inflammatory disorder","volume":"23","author":"Palmisano","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/art.21698","article-title":"Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin","volume":"55","author":"Martorana","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2020.102694_bb0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000658-199702000-00003","article-title":"Inflammatory aortic aneurysms. A clinical review with new perspectives in pathogenesis","volume":"225","author":"Rasmussen","year":"1997","journal-title":"Ann Surg"},{"issue":"9419","key":"10.1016\/j.autrev.2020.102694_bb0225","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(04)16100-X","article-title":"Asbestos exposure as a risk factor for retroperitoneal fibrosis","volume":"363","author":"Uibu","year":"2004","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.autrev.2020.102694_bb0230","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-017-0268-1","article-title":"Characteristics of immunoglobulin G4-related aortitis\/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography\/computed tomography co-registered with contrast-enhanced computed tomography","volume":"7","author":"Yabusaki","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.autrev.2020.102694_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejrad.2016.11.012","article-title":"IgG4-related cardiovascular disease. The emerging role of cardiovascular imaging","volume":"86","author":"Mavrogeni","year":"2017","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102694_bb0245","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.11102250","article-title":"Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients","volume":"261","author":"Inoue","year":"2011","journal-title":"Radiology."},{"issue":"4","key":"10.1016\/j.autrev.2020.102694_bb0250","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar4671","article-title":"Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a retrospective multicenter study","volume":"16","author":"Mizushima","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/acr.22058","article-title":"Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study","volume":"66","author":"Ebbo","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2020.102694_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-018-4046-9","article-title":"The many faces of IgG4-related disease: report of a case with inaugural recurrent aortic aneurism ruptures and literature review","author":"Luis","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2020.102694_bb0265","first-page":"282067","article-title":"The differential diagnosis of two cases of chronic periaortitis","volume":"2013","author":"Kato","year":"2013","journal-title":"Case Rep Radiol"},{"issue":"44","key":"10.1016\/j.autrev.2020.102694_bb0270","doi-asserted-by":"crossref","first-page":"16550","DOI":"10.3748\/wjg.v20.i44.16550","article-title":"Retroperitoneal disorders associated with IgG4-related autoimmune pancreatitis","volume":"20","author":"Hara","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102694_bb0275","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00259-015-3007-8","article-title":"Imaging large vessel vasculitis with fully integrated PET\/MRI: a pilot study","volume":"42","author":"Einspieler","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl. 103","key":"10.1016\/j.autrev.2020.102694_bb0280","first-page":"146","article-title":"Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging compared to clinical and laboratory parameters","volume":"35","author":"Thuermel","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102694_bb0285","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine."},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0295","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2020.102694_bb0300","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/annrheumdis-2011-201166","article-title":"Rituximab therapy for chronic periaortitis","volume":"71","author":"Maritati","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"42","key":"10.1016\/j.autrev.2020.102694_bb0305","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012631","article-title":"Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis","volume":"97","author":"Wallwork","year":"2018","journal-title":"Medicine."},{"key":"10.1016\/j.autrev.2020.102694_bb0310","article-title":"Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients","author":"Urban","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1538574413510616","article-title":"Inflammatory abdominal aortic aneurysm: a case report and review of literature","volume":"48","author":"Ketha","year":"2014","journal-title":"Vasc Endovascular Surg"},{"issue":"4","key":"10.1016\/j.autrev.2020.102694_bb0320","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.athoracsur.2013.11.074","article-title":"Surgical procedure in immunoglobulin G4-related ascending aortitis?","volume":"97","author":"Colombier","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.autrev.2020.102694_bb0325","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1038\/s41598-020-61585-z","article-title":"Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China","volume":"10","author":"Tang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102694_bb0330","first-page":"1","article-title":"Phenotyping of IgG4-related diseases based on affected organ pattern: a multicenter cohort study using cluster analysis","author":"Niwamoto","year":"2020","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102694_bb0335","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.carpath.2015.05.001","article-title":"Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. inflammatory diseases","volume":"24","author":"Stone","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.autrev.2020.102694_bb0340","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fimmu.2019.00693","article-title":"Clinical and prognostic significance of serum IgG4 in chronic periaortitis. An analysis of 113 patients","volume":"10","author":"Maritati","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102694_bb0345","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.carpath.2012.02.001","article-title":"Dense IgG4 plasma cell infiltrates associated with chronic infectious aortitis: implications for the diagnosis of IgG4-related disease","volume":"21","author":"Siddiquee","year":"2012","journal-title":"Cardiovasc Pathol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:37Z","timestamp":1761599977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1568997220302718"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102694","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of IgG4-related aortitis and periaortitis. A decade since their first description","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102694"}}